CME Group (NASDAQ:CME) Price Target Raised to $231.00

CME Group (NASDAQ:CME) had its price objective raised by research analysts at Barclays from $219.00 to $231.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has an “equal weight” rating on the financial services provider’s stock. Barclays‘s target price points to a potential upside of 2.15% from the stock’s previous close.

Several other analysts also recently issued reports on CME. JPMorgan Chase & Co. increased their price objective on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research report on Thursday, July 25th. Oppenheimer lifted their price target on shares of CME Group from $228.00 to $245.00 and gave the stock an “outperform” rating in a research note on Monday, October 14th. Keefe, Bruyette & Woods boosted their price objective on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. The Goldman Sachs Group raised their target price on CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research note on Thursday, October 3rd. Finally, Morgan Stanley boosted their price target on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 17th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $222.07.

CME Group Stock Down 1.5 %

Shares of NASDAQ CME opened at $226.14 on Thursday. The stock has a fifty day moving average price of $218.57 and a 200 day moving average price of $208.81. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group has a 12-month low of $190.70 and a 12-month high of $230.36. The company has a market cap of $81.43 billion, a P/E ratio of 25.70, a P/E/G ratio of 7.76 and a beta of 0.55.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.03. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company’s revenue was up 18.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.25 earnings per share. Research analysts anticipate that CME Group will post 10.04 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at $2,877,504.39. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.30% of the stock is owned by insiders.

Institutional Investors Weigh In On CME Group

A number of institutional investors and hedge funds have recently bought and sold shares of CME. Capital International Investors grew its stake in shares of CME Group by 24.1% in the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock worth $3,403,557,000 after purchasing an additional 3,069,806 shares during the last quarter. Ameriprise Financial Inc. boosted its holdings in CME Group by 11.3% during the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock worth $1,038,676,000 after buying an additional 537,758 shares in the last quarter. GUARDCAP ASSET MANAGEMENT Ltd grew its position in CME Group by 1.1% in the first quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 4,009,068 shares of the financial services provider’s stock worth $863,112,000 after buying an additional 43,293 shares during the last quarter. Raymond James & Associates increased its holdings in shares of CME Group by 3.2% in the second quarter. Raymond James & Associates now owns 3,029,145 shares of the financial services provider’s stock valued at $595,530,000 after buying an additional 94,302 shares in the last quarter. Finally, Legal & General Group Plc lifted its position in shares of CME Group by 6.6% during the 2nd quarter. Legal & General Group Plc now owns 2,835,075 shares of the financial services provider’s stock valued at $557,371,000 after acquiring an additional 176,004 shares during the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.